Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 10.99 Delayed Data As of 4:00pm ET |  +0.15 / +1.38%Today’s Change | 6.71 Today|||52-Week Range 14.15 | +4.27% Year-to-Date |
| The Highest-Yielding Drug Stocks Sep 29 / MotleyFool.com - Paid Partner Content |
| Previous close | 10.84 |
| Today’s open | 10.86 |
| Day’s range | 10.77 - 11.16 |
| Volume | 453,777 |
| Average volume (3 months) | 651,842 |
| Market cap | $1.2B |
| Dividend yield | 9.10% |
| Earnings growth (last year) | +89.33% |
| Earnings growth (this year) | +491.25% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +247.57% |
| P/E ratio | 64.6 |
| Price/Sales | 17.94 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| SUPNSupernus Pharmaceuti... | +0.10 | +0.41% |
| CEMPCempra Inc | +0.32 | +1.34% |
| DERMDermira Inc | +1.15 | +3.52% |
| PCRXPacira Pharmaceutica... | +0.20 | +0.59% |
| Next reporting date | October 27, 2016 |
| EPS forecast (this quarter) | $0.19 |
| Annual revenue (last year) | $67.8M |
| Annual profit (last year) | -$18.8M |
| Net profit margin | -27.68% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Michael W. Aguiar |
Chief Financial Officer & Senior Vice President Eric d'Esparbes |
Corporate headquarters South San Francisco, California |
